Literature DB >> 6260396

The opposing effects of chronic angiotensin-converting enzyme blockade by captopril on the responses to exogenous angiotensin II and vasopressin vs. norepinephrine in rats.

F Spertini, H R Brunner, B Waeber, H Gavras.   

Abstract

To study the influence of acute and chronic angiotensin-converting enzyme blockade on the pressor response to exogenous angiotensin II, vasopressin and norepinephrine, we gave normal female Wistar rats 100 mg of captopril or 1 ml of 5% glucose twice daily by gavage for 2 weeks. On the 15th day, rats were anesthetized with pentobarbital, and dose-response curves to angiotensin II, lysine-vasopressin, and norepinephrine were obtained before and after intraperitoneal injection of 100 mg/kg of captopril or 1 ml of 5% glucose. Acute as well as chronic converting enzyme blockade enhanced the pressor response to exogenous angiotensin II. Similarly, sensitivity to exogenous vasopressin was increased by both acute and chronic converting enzyme inhibition. In contrast, chronic converting enzyme blockade significantly blunted the response to exogenous norepinephrine, whereas acute blockade tended to accentuate its pressor effect. These results suggest that chronic angiotensin-converting enzyme blockade may partly inhibit sympathetic activity which, in turn, might contribute to the antihypertensive efficacy of this therapeutic approach. These results also point to an important physiological interaction between the two pressor hormones, angiotensin II and vasopressin.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6260396     DOI: 10.1161/01.res.48.5.612

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  5 in total

Review 1.  Long-range safety and protective benefits of angiotensin-converting enzyme inhibitors for hypertension. Do we need more clinical trials?

Authors:  M P Sambhi; H Gavras; J I Robertson; W M Smith
Journal:  West J Med       Date:  1993-03

2.  Vasopressin reduces cardiac function and augments cardiopulmonary baroreflex resistance increases in man.

Authors:  T J Ebert; A W Cowley; M Skelton
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

3.  Cardiovascular interactions between vasopressin, angiotensin and noradrenaline in the Brattleboro rat.

Authors:  J F Laycock; S L Lightman
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

4.  Effect of captopril and hydrochlorothiazide on the response to pressor agents in hypertensives.

Authors:  R J Fruncillo; H H Rotmensch; P H Vlasses; J R Koplin; B N Swanson; R K Ferguson
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

5.  Compared myocardial and vascular effects of captopril and dihydralazine during hypertension development in spontaneously hypertensive rats.

Authors:  J L Freslon; J F Giudicelli
Journal:  Br J Pharmacol       Date:  1983-11       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.